diarrhea in Extend­ed release study [Outliers]

posted by Researcher101 – Egypt, 2020-09-23 23:53 (989 d 23:36 ago) – Posting: # 21935
Views: 1,057

Dear All, I'm asking if I have a study on product containing two actives (one IR and the other extended release) and a participant had a diarrhea after Tmax of the IR active and through the Tmax of the XR active. should I exclude the participant from the study? or include him in the XR active statistical calculation and exclude in the IR? :confused:

Complete thread:

UA Flag
Activity
 Admin contact
22,627 posts in 4,743 threads, 1,613 registered users;
18 visitors (0 registered, 18 guests [including 12 identified bots]).
Forum time: 23:30 CEST (Europe/Vienna)

Learn the rules like a pro,
so you can break them like an artist.    attributed to Pablo Picasso

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5